A. Perlman

Bortezomib for Reduction of Proteinuria in IgA Nephropathy

T. Muthukumar, C. Hartono, D. Serur, 2018, Kidney international reports.

Concomitance of IgA nephropathy and diabetic nephropathy in a kidney allograft: case report and review of the literature.

C. Hartono, S. Salvatore, A. Perlman, 2014, Transplantation proceedings.

Angiotensin II regulation of TGF-beta in murine mesangial cells involves both PI3 kinase and MAP kinase.

M. Saji, A. Perlman, M. D. Ringel, 2004, Annals of clinical and laboratory science.

A Mobile Health–Based Survey to Assess COVID-19 Vaccine Intent and Uptake Among Patients on Dialysis

Meghan Reading Turchioe, T. Parker, D. Levine, 2021, Kidney International Reports.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Debra F. Weinstein, Michael G. Miller, M. A. Ferreira, 2019, Lancet.

Serum Inflammatory and Immune Mediators Are Elevated in Early Stage Diabetic Nephropathy.

F. Farrell, T. Parker, D. Levine, 2015, Annals of clinical and laboratory science.

Prevention of Recurrent Episodes of Rhabdomyolysis With Tacrolimus in a Transplant Recipient With Myopathy

A. Perlman, R. Baskharoun, S. Sathyan, 2014, American journal of therapeutics.

Acute Pancreatitis after Consuming 3 . 5 Lbs of Cassava

A. Perlman, L. Kao, Lilian Saro-Nunez, 2015 .

Minimal change disease: an unusual presentation of marginal zone MALT lymphoma.

S. Seshan, Faisal Inayat, Jason H. K. Law, 2016, Clinical nephrology.

Multiparametric Quantitative Ultrasound Imaging in Assessment of Chronic Kidney Disease

L. Waldron, S. Seshan, S. Salvatore, 2017, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Debra F. Weinstein, Michael G. Miller, M. A. Ferreira, 2019, Lancet.